Page 3 - Pharma Exports

Exports decline for second month in a row, trade deficit at ten-month high

Exports fell sharper at 8.7% in November from 5.1% in October, as demand remained muted in major overseas markets due to Covid-induced lockdowns

September recovery proves short-lived as exports fall 5% in Oct

Covid-induced lockdowns in advanced nations hit exports, trade deficit at nine-month high

Credit metrics of leading pharma companies to remain stable: ICRA

The global demand scenario for Indian pharmaceutical industry is largely expected to remain stable due to inelastic nature of prescription drugs, investment information agency ICRA has said.

Export figures for Aug disappoint optimists

Among manufactured goods, only drugs & pharmaceuticals and plastic and linoleum have shown positive growth

Domestic pharma market to grow 12-14% in 3 years, exports by 8-14%: KPMG

The country ranks as the third-largest pharma market globally by volume and 13 largest by value

Antiviral drugs see demand surge in India, but segment declines 5.5%

Data from market research firm AIOCD-AWACS shows that sales of oseltamivir (common brand Tamiflu), used against the influenza virus and also for swine flu, went up by 35.8 per cent in April

Drug to treat Covid-19 ready, says Strides Pharma; stock rises 20%

Firm says will apply to Indian pharma authorities to start studies

Covid-19: India allows paracetamol formulation export, retains curbs on API

Pharma industry welcomes decision, but wants govt to consider allowing export of APIs made before March 3

Europe 'panicking' over India's pharma export curbs: Industry body

India's list of restricted medicines account for 10 per cent of its total pharmaceutical exports and includes several antibiotics, as well as Paracetamol

Coronavirus: Govt restricts exports of 26 active pharma drugs, formulations

India on Monday reported two new cases of the novel coronavirus, including one from the national capital. The outbreak has killed more than 3,000 people globally

Pharma industry poised to beat FY19 exports despite strict US regulations

April-December exports rise 11.5%; estimates peg FY20 numbers at $22 billion

Pharma companies can draw $30 bn revenue from US market by tapping 10 drugs

Despite having good demand from across the markets, primarily due to lower prices and easy availability, India controls only 2.4 per cent of global pharma exports

Q3 results preview: US regulatory overhang on earnings of pharma firms

The US is Indian pharma's largest export market and Indian drugmakers account for a little over 30 per cent of generic drugs sold in that country

Indian pharma exports hit $19.14 bn, report double-digit growth after 3 yrs

Indian pharma exports registered a double-digit growth of 10.17 per cent at $16.89 billion last time in 2015-16

State drug controllers get power to issue NOCs for drugs meant for export

BS ReporterHyderabad, 3 August: State drug controllers have been given complete jurisdiction to issue no objection certificates(NOCs) for manufacture of unapproved, banned or new drugs that are solely meant for exports. The Drug Control General of India (DCGI) discontinued the earlier practice wherein the grant of such NoCs were being overseen by the Central Drugs Standard Control Organisation(CDSCO). These orders will come into effect from August 20, 2018.The Pharmaceutical Export Promotion Council of India (Pharmexcil) has recently approached the drug regulator seeking a waiver of bio equivalence(BE) studies for grant of license of oral dosage form of drugs specified under BCS category 2 and 4 for export purpose.Drug controllers in some states were insisting on submission of results of BE studies endorsed by the CDSO for grant of license to manufacture such drugs for export purpose and this has been causing difficulties to the exporters, according to Pharmexcil. "In order to ...

Pharma exports see double digit growth after a gap of three years

In April, pharma exports to the US has grown by 17.47 per cent as compared to a 10 per cent decline in the same month last year

Lax industry norms, tough entry process slows pharma exports to China

Currently, pharma shipments make up only 0.3% of the total $13.33 billion exports to China

How the pharma growth story fizzled out

Pharma exports now seem to be losing their importance due to poor growth

Growth in Indian pharma exports revives in the third quarter

Hyderabad, 27 FebruaryIndian pharma exports have increased 5.6 per cent to $ 4,357 million during October-December period in this financial year over the same quarter previous fiscal, as per the Pharmaceuticals Export Promotion Council (Pharmexcil) data. The pharma body, which works under the Union Commerce Ministry, expects the rise in exports in the second half of this year to more than compensate for a marginal decline in the exports during April-October period.India has seen 9.7 per cent increase in pharma exports at $16.89 billion in the last financial year. The January-March quarter is likely to add further momentum to the export growth seen in the October-December period, according to Pharmexcil director general Ravi Uday Bhaskar. The country has 700 drug manufacturing units registered with the US Food and Drug Administration (USFDA). More than 30 per cent of abbreviated new drug applications (ANDAs) granted by the USFDA in 2016 are from India. This indicates an upward trend ..